Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Anacor Pharmaceuticals Inc.

Division of Pfizer Inc.
www.anacor.com

Latest From Anacor Pharmaceuticals Inc.

Pfizer's Business Development Transition: From "Revenues Now" To Pipeline Development

Pfizer will be active in business development, management said, but with a focus on building out the pipeline with bolt-on deals in the range of a "few billion." Gene therapy remains one area of interest.

Sales & Earnings Deals

Appointments: Lilly, Kiadis, Pliant, Alma, NeuroVia and Nektar Therapeutics

This week's roundup includes a handful of promotions by Eli Lilly, and various board and high-level appointments by companies including Kiadis Pharma, Aeterna Zentaris, Dermavant Sciences and Pliant Therapeutics.

Appointments BioPharmaceutical

Gates Foundation’s $40m Incentivizes Cancer Specialist Immunocore To Develop TB, HIV Drugs

Oxford, UK-based Immunocore, which is developing immunotherapies against cancer, has secured $40m in funding from the Bill & Melinda Gates Foundation to boost its research activities in infectious diseases. The company hopes to develop novel therapeutics to reduce treatment timelines and improve outcomes for patients with HIV and TB.

Deals Infectious Diseases

Sienna CEO: IPO Investors Drawn By Experienced Dermatology Team

Sienna Biopharmaceuticals went from Series A to IPO in 15 months, selling investors on its executive team experienced in the development and commercialization of dermatology and aesthetic products.

Financing Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Dermatology
  • Infectious & Viral Diseases
  • Inflammation
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pfizer Inc.
  • Senior Management
  • Paul L Berns, Pres. & CEO
    Erik D Wiberg, VP, Bus. Dev.
    Lee T Zane, MD, SVP & CMO
    Vince Ippolito, Chief Commercial Officer
    Jacob J Plattner, PhD, SVP, Research
  • Contact Info
  • Anacor Pharmaceuticals Inc.
    Phone: (650) 543-7500
    1020 E. Meadow Cir.
    Palo Alto, CA 94303-4230
    USA
UsernamePublicRestriction

Register